With a clinical version of PathAI‘s computer vision-based pathogen detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in its latest round of financing. The company’s tech is used by doctors to analyze cell samples taken from patients to determine the presence or absence of […]...